Hester Biosciences Ltd. - Research Center
524669 HESTERBIO Group (B) BSE data
Results
Statement
More
| Mar ' 23 |
Mar ' 22 |
Mar ' 21 |
Mar ' 20 |
Mar ' 19 |
Equity share capital
Share application money
Preference share capital
Reserves & surplus
| 283.88 |
259.93 |
229.07 |
194.57 |
170.93 |
Secured loans
| 164.32 |
121.91 |
4.39 |
39.25 |
32.30 |
Unsecured loans
Total
| 456.70 |
390.35 |
241.97 |
242.33 |
211.74 |
Gross block
| 197.94 |
170.25 |
163.77 |
165.49 |
160.84 |
Less : revaluation reserve
Less : accumulated depreciation
| 89.72 |
85.94 |
77.13 |
69.02 |
60.25 |
Net block
| 108.22 |
84.31 |
86.64 |
96.47 |
100.60 |
Capital work-in-progress
| 148.61 |
81.91 |
3.59 |
1.16 |
0.63 |
Investments
| 64.69 |
64.69 |
43.89 |
40.67 |
28.22 |
Current assets, loans & advances
| 224.30 |
193.54 |
147.90 |
138.88 |
110.80 |
Less : current liabilities & provisions
| 89.11 |
34.10 |
40.05 |
34.86 |
28.50 |
Total net current assets
| 135.19 |
159.44 |
107.85 |
104.02 |
82.30 |
Miscellaneous expenses not written
Total
| 456.70 |
390.35 |
241.97 |
242.33 |
211.74 |
Book value of unquoted investments
| 64.69 |
64.69 |
43.89 |
40.67 |
28.22 |
Market value of quoted investments
Contingent liabilities
| 241.23 |
276.50 |
104.93 |
107.06 |
29.36 |
Number of equity sharesoutstanding (Lacs)
| 85.07 |
85.07 |
85.07 |
85.07 |
85.07 |